Skip to main content
. 2021 Nov 29;27:10760296211050642. doi: 10.1177/10760296211050642

Table 1.

Clinical Data of the Study Population.

Features Healthy controls (n = 68) AS patients (n = 110) P value
Age (years) 52.69 ± 3.74 53.43 ± 4.59 .239
Gender (male/female) 35/33 59/51 .780
BMI (kg/m2) 24.41 ± 3.06 25.09 ± 2.51 .128
Total cholesterol (mg/dl) 199.25 ± 9.76 201.39 ± 12.21 .221
HDL-C (mg/dl) 46.69 ± 7.36 48.50 ± 10.87 .187
LDL-C (mg/dl) 115.97 ± 14.29 117.44 ± 12.33 .469
Triglyceride (mg/dl) 168.56 ± 22.53 173.58 ± 20.68 .130
Heart rate (beats/min) 74.05 ± 16.67 76.60 ± 15.38 .299
SBP (mm Hg) 131.43 ± 9.91 134.47 ± 16.42 .125
DBP (mm Hg) 88.75 ± 6.50 88.27 ± 5.27 .593
CRP (mg/l) 6.24 ± 1.53 12.19 ± 2.43 .000
Medication
 ACE-I/ARB 15 38 .077
 β-Blockers 3 21 .005
 Statins 10 18 .768

Abbreviations: AS, atherosclerosis; BMI, Body Mass Index; CIMT, Carotid Intima Media Thickness; CRP, C-reactive protein; DBP, Diastolic Blood Pressure; HDL-C, high-density lipoproteincholesterol; LDL-C, low-density lipoproteincholesterol; SBP, Systolic Blood Pressure.